Mission
THE PRIMARY PURPOSE OF MAXAID IS TO CARRY OUT TREATMENT ACCESS SOLUTIONS FOR ONCOLOGY AND OTHER CRITICAL ILLNESS PRODUCTS IN LOW AND MIDDLE INCOME COUNTRIES IN SUPPORT OF THE MAX FOUNDATION'S MISSION.
Based in SEATTLE, WA, MAXAID operates as a Public Charity. The organization reported $309.1M in revenue, $371.0M in expenses, $73.6M in total assets for fiscal year 2024.
THE PRIMARY PURPOSE OF MAXAID IS TO CARRY OUT TREATMENT ACCESS SOLUTIONS FOR ONCOLOGY AND OTHER CRITICAL ILLNESS PRODUCTS IN LOW AND MIDDLE INCOME COUNTRIES IN SUPPORT OF THE MAX FOUNDATION'S MISSION.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $309.1M | $371.0M | $73.6M |
| 2023 | $311.1M | $295.2M | $136.8M |
| 2022 | $317.9M | $374.2M | $121.8M |
| 2021 | $455.6M | $470.8M | $177.4M |
| 2020 | $521.8M | $439.4M | $193.3M |
Between 2020 and 2024, reported annual revenue declined from $521.8M to $309.1M (-41%), with total assets most recently reported at $73.6M.
Interactive year-over-year charts and full filing details available with membership.